2,2',4,4'-Tetrabromodiphenyl ether


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:17361017IVR100 mg/kg/day 100 mg/kg/dayIncreased uterine weightsReproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayAffects neuronal signalingNeurological endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayIncreased uterine weightsReproductive endocrine-mediated perturbations
IVR100 mg/kg/day 100 mg/kg/dayAffects neuronal signalingNeurological endocrine-mediated perturbations
IVR50 mg/kg/day 50 mg/kg/dayAffects neuronal signalingNeurological endocrine-mediated perturbations
IVR50 mg/kg/day 50 mg/kg/dayIncreased uterine weightsReproductive endocrine-mediated perturbations
PMID:17964624IVR100 mg/kg/day 100 mg/kg/dayAffects xenobiotic metabolismMetabolic endocrine-mediated perturbations
IVR100 mg/kg/day 100 mg/kg/dayIncreased liver weightsHepatic endocrine-mediated perturbations
IVR100 mg/kg/day 100 mg/kg/dayDecrease in T4 levelsMetabolic endocrine-mediated perturbations
IVR100 mg/kg/day 100 mg/kg/dayAffects thyroid functionMetabolic endocrine-mediated perturbations
IVR3 mg/kg/day 3 mg/kg/dayCancer phenotypeEndocrine-mediated cancer
IVR3 mg/kg/day 3 mg/kg/dayAffects xenobiotic metabolismMetabolic endocrine-mediated perturbations
IVR10 mg/kg/day 10 mg/kg/dayAffects thyroid functionMetabolic endocrine-mediated perturbations
IVR10 mg/kg/day 10 mg/kg/dayAffects xenobiotic metabolismMetabolic endocrine-mediated perturbations
PMID:18335096IVR0.14 mg/kg 0.14 mg/kgAffects folliculogenesisReproductive endocrine-mediated perturbations
IVR0.14 mg/kg 0.14 mg/kgDecreased ovarian weights in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR0.14 mg/kg 0.14 mg/kgDecreased liver weightsHepatic endocrine-mediated perturbations
IVR0.14 mg/kg 0.14 mg/kgDecreased estradiol levelsReproductive endocrine-mediated perturbations
IVR0.7 mg/kg 0.7 mg/kgDecreased estradiol levelsReproductive endocrine-mediated perturbations
IVR0.7 mg/kg 0.7 mg/kgIncreased weights of thyroid glandMetabolic endocrine-mediated perturbations
IVR0.7 mg/kg 0.7 mg/kgDecreased ovarian weights in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR0.7 mg/kg 0.7 mg/kgDecreased liver weightsHepatic endocrine-mediated perturbations
IVR0.7 mg/kg 0.7 mg/kgAffects folliculogenesisReproductive endocrine-mediated perturbations
PMID:22233939IVTH0.00000000000001 - 0.0001 M 0.0000000001 - 0.00000001 MCancer phenotypeEndocrine-mediated cancer
IVTH0.00000000000001 - 0.0001 M 0.0000000001 - 0.00000001 MOxidative stress in liverHepatic endocrine-mediated perturbations
PMID:26217518IVR1 mg/kg/day 1 mg/kg/dayAffects glucose metabolismMetabolic endocrine-mediated perturbations
PMID:27449334IVR5 mg/kg 5 mg/kgInduce apoptosis of ovarian folliclesReproductive endocrine-mediated perturbations
IVR1 mg/kg 1 mg/kgInduce apoptosis of ovarian folliclesReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgInduce apoptosis of ovarian folliclesReproductive endocrine-mediated perturbations
PMID:28712647IVR0.2 mg/kg 0.2 mg/kgAlterations in immune responsesImmunological endocrine-mediated perturbations
IVR0.2 mg/kg 0.2 mg/kgDecreased testis weightsReproductive endocrine-mediated perturbations
IVR0.2 mg/kg 0.2 mg/kgAbnormal sperm morphologyReproductive endocrine-mediated perturbations
IVR0.2 mg/kg 0.2 mg/kgAffects testicular functionReproductive endocrine-mediated perturbations
IVR0.2 mg/kg 0.2 mg/kgAffects spermatogenesisReproductive endocrine-mediated perturbations
PMID:29112739IVR1 mg/kg 1 mg/kgElevated glucose levelsMetabolic endocrine-mediated perturbations
IVR10 mg/kg -No significant effects observed-
PMID:30849655IVTH0.000001 M 0.000001 MAffects liver functionHepatic endocrine-mediated perturbations
IVTH0.00000001 M 0.00000001 MAffects liver functionHepatic endocrine-mediated perturbations
IVTH0.0000001 M 0.0000001 MAffects liver functionHepatic endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.